Thermo Fisher Scientific has launched a compliance and services portfolio, compatible with current Good Manufacturing Practice (cGMP), designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.

Developed to simplify and optimize the cGMP equipment installation and validation processes, the Thermo Scientific Cell Therapy Systems (CTS) Series Laboratory Equipment are comprised of a range of key lab equipment routinely used in cell and gene therapy manufacturing, including biological safety cabinets, centrifuges, CO2 incubators and cold storage systems. Each product includes a factory acceptance test documentation package comprised of operating certificates, performance specifications, user guides and technical manuals. The portfolio is also supported by field compliance services, including installation setup, IQ, OQ and other support, such as temperature mapping and calibration.

The CTS Series Laboratory Equipment are manufactured at ISO13485-certified sites, and designed to meet global mechanical and electrical safety standards.

Originally posted here:

Thermo Fisher Launches Cell And Gene Therapy Mfg. Offering - Contract Pharma